ArticleRSC advances2025
Silane-crosslinked graphene oxide reinforced chitosan/sodium alginate hydrogel for controlled release of insulin.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Anti-Swelling Hydrogel Wearable Sensors: Structural Engineering, Internal Water Environment Regulation, and Motion Monitoring in Complex Environments.Gels (Basel, Switzerland) · 2026Review
- Efficient preparation of size-controlled sodium alginate microspheresRSC advances · 2026Article
- Hydrogels-Advanced Polymer Platforms for Drug Delivery.Polymers · 2026Review
- Liposomal Nanosystems Versus Hydrogels in the Prevention and Treatment of Metabolic Diseases.Gels (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic patients require regular insulin administration to maintain standard glucose. However, conventional injection procedures frequently lead to low patient compliance and an elevated risk of hypoglycemia. To overcome these challenges, a hydrogel-based system has been developed, with preliminary findings suggesting its potential for sustained insulin release while exhibiting pH-responsiveness and biocompatibility. A hydrogel composed of chitosan, sodium alginate, and graphene oxide (GO) crosslinked with tetra ethoxy silane (TEOS) was synthesized
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.